INNV
Innovage Holding Corp
NASDAQ · Health Care
$8.36
+0.89 (+11.91%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 855.67M | 800.36M | 168.13M | 151.43M | 173.46M |
| Net Income | -30,383,109 | -25,577,399 | 12.45M | 11.49M | 11.00M |
| EPS | — | — | — | — | — |
| Profit Margin | -3.6% | -3.4% | 7.4% | 7.6% | 6.3% |
| Rev Growth | +6.9% | +6.9% | +0.0% | +12.7% | +1.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 133.73M | 133.73M | 373.43M | 399.52M | 398.80M |
| Total Equity | 433.49M | 433.49M | 568.23M | 519.27M | 520.32M |
| D/E Ratio | 0.31 | 0.31 | 0.66 | 0.77 | 0.77 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -8,535,496 | -7,584,623 | 19.34M | 18.06M | 21.97M |
| Free Cash Flow | — | — | 13.64M | 15.16M | 15.93M |